AAAAAA

   
Results: 1-25 | 26-30 |
Results: 26-30/30
A COST-ANALYSIS OF TOPICAL DRUG REGIMENS FOR DERMATOPHYTE INFECTIONS
Authors: CHREN MM LANDEFELD CS
Citation: Mm. Chren et Cs. Landefeld, A COST-ANALYSIS OF TOPICAL DRUG REGIMENS FOR DERMATOPHYTE INFECTIONS, JAMA, the journal of the American Medical Association, 272(24), 1994, pp. 1922-1925
PHYSICIANS BEHAVIOR AND THEIR INTERACTIONS WITH DRUG COMPANIES - A CONTROLLED-STUDY OF PHYSICIANS WHO REQUESTED ADDITIONS TO A HOSPITAL DRUG FORMULARY
Authors: CHREN MM LANDEFELD CS
Citation: Mm. Chren et Cs. Landefeld, PHYSICIANS BEHAVIOR AND THEIR INTERACTIONS WITH DRUG COMPANIES - A CONTROLLED-STUDY OF PHYSICIANS WHO REQUESTED ADDITIONS TO A HOSPITAL DRUG FORMULARY, JAMA, the journal of the American Medical Association, 271(9), 1994, pp. 684-689
COSTS OF TOPICAL DRUG REGIMENS FOR DERMATOPHYTE INFECTIONS
Authors: CHREN MM
Citation: Mm. Chren, COSTS OF TOPICAL DRUG REGIMENS FOR DERMATOPHYTE INFECTIONS, Journal of investigative dermatology, 102(4), 1994, pp. 581-581
INDEPENDENT INVESTIGATORS AND FOR-PROFIT COMPANIES - GUIDELINES FOR BIOMEDICAL SCIENTISTS CONSIDERING FUNDING BY INDUSTRY
Authors: CHREN MM
Citation: Mm. Chren, INDEPENDENT INVESTIGATORS AND FOR-PROFIT COMPANIES - GUIDELINES FOR BIOMEDICAL SCIENTISTS CONSIDERING FUNDING BY INDUSTRY, Archives of dermatology, 130(4), 1994, pp. 432-437
SEVERE MEGALOBLASTIC-ANEMIA IN A PATIENT RECEIVING LOW-DOSE METHOTREXATE FOR PSORIASIS
Authors: CASSERLY CM STANGE KC CHREN MM
Citation: Cm. Casserly et al., SEVERE MEGALOBLASTIC-ANEMIA IN A PATIENT RECEIVING LOW-DOSE METHOTREXATE FOR PSORIASIS, Journal of the American Academy of Dermatology, 29(3), 1993, pp. 477-480
Risultati: 1-25 | 26-30 |